CDC Vaccine Committee Revisits Hepatitis B

A recent decision by the Advisory Committee on Immunization Practices downgrades the recommendation for hepatitis B vaccination at birth, which had been the standard of care since 1991.  

The committee no longer recommends the vaccination for all newborns. In instances where the infant’s mother is not positive for hepatitis B, the committee instead recommends that parents engage in individual-based decision-making. Consultation with a clinician is recommended as parents explore the risks and benefits for their infant.   

A Proven Public Health Tool in Jeopardy 

More than 2 million people in the United States live with hepatitis B, and the recommended vaccination schedule for infants is a crucial component of public health protection. Given the pervasive risk of the virus, pregnant mothers could initially test negative early in their pregnancy and unknowingly pass it to their baby later. The prophylactic dose administered within 24 hours of birth serves as a safeguard against a mostly silent and symptomless killer.  

Infants infected with hepatitis B in the womb or at birth face a 90% chance of chronic infection, with long-term risks that include liver disease and cancer. Vaccination promptly after birth has been shown to reduce the risk of infection and later complications. 

Patient Advocates Sound the Alarm  
 
More than 40 leading advocacy organizations representing clinicians and patients have signed a statement attesting to the vaccine’s safety and effectiveness. They cite potential risks to newborns and disruptions to continuity of care. The birth dose has long functioned as a safety net, protecting infants regardless of future access to care and the reliability of maternal screening. 

 Balancing Choice and Prevention 

Shared decision-making and informed consent are key drivers of modern health care. While parental engagement is vital, variability in vaccine timing may introduce new challenges for both pediatric care teams and children who become infected. Careful attention will be required to ensure that newborns remain protected during a uniquely vulnerable period of life.